A new analysis of year-to-date 2024 patent filings, NIH funding, and real estate data reveals a fiercely competitive landscape in America’s biopharma clusters. Boston/Cambridge maintains its overall leadership position and leads in YTD international pharma patent filings, while the New York/New Jersey metro area leads in NIH funding for FY2025 and ranks second in patents.…